OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

SKU Category Vector Description Price Delivery
RC217191 CDNA CLONE PS100001 MAP4K5 (Myc-DDK-tagged)-Human mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5), transcript variant 1 $560 Immediate
RC217191L1 CDNA CLONE PS100064 Lenti ORF clone of Human mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5), transcript variant 1 , Myc-DDK-tagged $740 Immediate
RC217191L1V CDNA CLONE PS100064 Lenti ORF particles, MAP4K5 (Myc-DDK tagged) - Human mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5), transcript variant 1 , 200ul, >10^7 TU/mL $1140 2-3 weeks
RC217191L2 CDNA CLONE PS100071 Lenti ORF clone of Human mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5), transcript variant 1, mGFP tagged $810 3-4 weeks
RC217191L2V CDNA CLONE PS100071 Lenti ORF particles, MAP4K5 (mGFP-tagged) - Human mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5), transcript variant 1, 200ul, >10^7 TU/mL $1250 6-7 weeks
RG217191 CDNA CLONE PS100010 MAP4K5 (GFP-tagged) - Human mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5), transcript variant 1 $610 2-3 weeks
SC110237 CDNA CLONE pCMV6-XL4 MAP4K5 (untagged)-Human mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5), transcript variant 1 NM_006575.3 $190 Immediate
SC323591 CDNA CLONE pCMV6-XL4 MAP4K5 (untagged)-Kinase deficient mutant (K49M) of Human mitogen-activated protein kinase kinase kinase kinase 5 (MAP4K5), transcript variant 1 NM_006575.3 $700 Immediate
Still don't see what you are looking for? Try the comprehensive search
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title